WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Net Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹-198 Cr | ₹-189 Cr | ₹-258 Cr | ₹-217 Cr | ₹-263 Cr |
What is the latest Net Current Assets ratio of WANBURY ?
Year | Net Current Assets |
---|---|
Mar2023 | ₹-198 Cr |
Mar2022 | ₹-189 Cr |
Mar2021 | ₹-258 Cr |
Mar2020 | ₹-217 Cr |
Mar2019 | ₹-263 Cr |
How is Net Current Assets of WANBURY Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹-198 Cr | Negative | |
Mar2022 | ₹-189 Cr | Negative | |
Mar2021 | ₹-258 Cr | Negative | |
Mar2020 | ₹-217 Cr | Negative | |
Mar2019 | ₹-263 Cr | - |
Compare Net Current Assets of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹499.3 Cr | -5.7% | 7.9% | 228.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -5.7% |
7.9% |
228.5% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses